KAZN

Kazrin is a multifunctional adaptor protein that links cytoskeletal and junctional components to intracellular signaling and membrane trafficking pathways, with isoform-specific roles in cell adhesion, differentiation, and endosomal transport. Kazrin directly binds periplakin and localizes to desmosomes and the cornified envelope in keratinocytes, while its interaction with ARVCF-catenin, β2-spectrin, and p190B RhoGAP modulates RhoA activity to regulate actin organization, intercellular adhesion, and epidermal differentiation (PMID:15337775, PMID:18840647, PMID:21062899). The kazrin C isoform functions as a dynein/dynactin adaptor: its N-terminal domain binds dynactin and dynein light intermediate chain 1, while its C-terminal intrinsically disordered region contacts early endosome components, thereby promoting retrograde transport of early endosomes to recycling endosomes (PMID:37096882). Kazrin also participates in craniofacial morphogenesis through functional interplay with ARVCF-catenin and delta-catenin during neural crest development, and the kazrin F isoform suppresses apoptosis via interactions with ARC and Bax (PMID:22028074, PMID:19727525).

1. 2004 High

   Identification of kazrin as a periplakin-interacting protein established it as a desmosome-associated adaptor incorporated into the cornified envelope, raising the question of its broader role in epidermal architecture.

   Evidence Co-immunoprecipitation, immunofluorescence colocalization, and cornified envelope fractionation in keratinocytes

   PMID:15337775

   Open questions at the time

   • No functional perturbation was performed to assess consequences of kazrin loss
   • Whether kazrin has roles beyond the desmosome/cornified envelope was unknown
   • Binding partners other than periplakin were not identified
2. 2005 Medium

   Dynamic localization of kazrin to spindles, cytokinetic rings, and junctions across mouse preimplantation development revealed cell cycle-dependent redistribution, suggesting functions beyond epidermal adhesion.

   Evidence Confocal immunofluorescence across mouse oocyte and preimplantation stages

   PMID:16086310

   Open questions at the time

   • No functional perturbation was performed in embryos
   • Whether localization reflects active function at each site was not tested
   • Binding partners at the spindle were not identified
3. 2008 High

   Gain- and loss-of-function experiments in keratinocytes demonstrated that kazrin regulates actin organization, intercellular junction assembly, and terminal differentiation through modulation of RhoA activity, establishing it as a signaling modulator rather than merely a structural component.

   Evidence Overexpression and siRNA knockdown in primary human keratinocytes with Rho activity pulldown, phalloidin staining, and differentiation assays

   PMID:18840647

   Open questions at the time

   • The molecular mechanism linking kazrin to RhoA suppression was not identified
   • Whether effects are direct or through intermediary proteins was unclear
4. 2009 Medium

   Discovery that the kazrin F isoform interacts with ARC and Bax and that its knockdown triggers apoptosis established an isoform-specific anti-apoptotic function.

   Evidence Co-immunoprecipitation, siRNA knockdown, MTT and TUNEL assays in cell lines

   PMID:19727525

   Open questions at the time

   • No domain mapping or mutagenesis was performed to define interaction interfaces
   • Mechanism by which kazrin F suppresses Bax activation was not elucidated
   • Not independently confirmed in a second laboratory
5. 2010 High

   Biochemical resolution of a ternary ARVCF–kazrin–β2-spectrin complex and identification of p190B RhoGAP as a kazrin partner explained the molecular basis for kazrin's regulation of RhoA: kazrin stabilizes ARVCF-catenin and recruits a RhoGAP to control cortical actin and cadherin function.

   Evidence GST pulldown, ternary complex co-IP, Xenopus morpholino knockdown with ARVCF/p190B rescue

   PMID:21062899

   Open questions at the time

   • Whether the ternary complex forms in mammalian cells was not shown
   • Structural basis of the interactions was not determined
   • Contribution of delta-catenin and p0071 binding was not functionally tested
6. 2011 Medium

   Demonstration that kazrin depletion disrupts craniofacial cartilage and neural crest migration in Xenopus, rescuable by ARVCF, extended kazrin's roles from epithelial adhesion to embryonic morphogenesis.

   Evidence Morpholino knockdown in Xenopus with molecular marker and rescue analysis

   PMID:22028074

   Open questions at the time

   • Mammalian relevance of the craniofacial phenotype was not established
   • Whether effects are cell-autonomous in neural crest was not resolved
7. 2012 Medium

   Domain dissection via a gene-trap mouse showed that the N-terminal coiled-coil domain (exons 1–4) suffices for keratinocyte shape changes and that the C-terminal half is dispensable for skin homeostasis in vivo, narrowing the functionally critical region.

   Evidence Gene-trap mouse expressing exons 1–4-β-gal, truncation transfection, immunohistochemistry

   PMID:22513779

   Open questions at the time

   • The gene-trap allele was hypomorphic, not a full null, so residual function could mask phenotypes
   • Non-epidermal tissues were not comprehensively analyzed
8. 2023 High

   Identification of kazrin C as a bona fide dynein/dynactin adaptor that links the motor complex to early endosomes resolved a new isoform-specific function: promoting retrograde transport from early to recycling endosomes.

   Evidence In vitro binding assays, kazrin-knockout MEFs, live-cell endocytic trafficking and retrograde motility quantification

   PMID:37096882

   Open questions at the time

   • In vivo physiological consequences of disrupted endosomal transport in kazrin-null animals were not reported
   • Whether the dynein-adaptor and desmosome/RhoA functions are coordinated or independent in the same cell type is unknown
   • Structural basis of the N-terminal dynactin/LIC1 interaction was not determined

• How kazrin's multiple isoform-specific functions — desmosomal adhesion, RhoA regulation, endosomal trafficking, and apoptosis suppression — are integrated within individual cell types, and whether kazrin loss causes a mammalian developmental or disease phenotype, remain open questions.
• No full kazrin-null mouse phenotype has been comprehensively reported
• No structural data exist for any kazrin domain or complex
• Integration of the dynein-adaptor and cell adhesion functions has not been tested